Associated Papers
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA et al.
Acta Neuropathologica Communications, 2020
33087175 (PubMed )
Supplement: 40478_2020_1040_MOESM1_ESM.xlsx › Sheet1
Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study.
Weeber F et al.
Oncotarget, 2017
28903445 (PubMed )
Supplement: oncotarget-08-55582-s002.xlsx › Suppl_table_1
Select a paper to view details